Accel has 58 tracked deals to Goldman Sachs's 27. Stage focus, check size, and sector fit compared side by side.
Accel is an active investor with 58 tracked deals. Goldman Sachs is a accelerator based in Chicago, IL, United States with 27 tracked deals. Accel shows 31 more tracked rounds than Goldman Sachs in this dataset, which is the clearest signal of deployment pace between the two. Recent tracked names include Alyssum Therapeutics and Anysphere for Accel and Alterome Therapeutics and Amount for Goldman Sachs.
Investors like Accel · Investors like Goldman Sachs · Accel co-investors · Full investor directory